vimarsana.com

Luca Scavo News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cytovia Therapeutics appoints CFO, chief product officer

Cytovia Therapeutics, a Florida company with research-and-development operations in Natick, has named a chief financial officer and a chief product officer, as the company advances towards clinical trials and prepares to go public.

Evelo Biosciences, Inc : Evelo Biosciences Reports First Quarter 2021 Financial Results and Business Highlights

Evelo Biosciences, Inc.: Evelo Biosciences Reports First Quarter 2021 Financial Results and Business Highlights -Presented further positive data from Phase 1b clinical trial of EDP1815 at International Society of Atopic Dermatitis Meeting- -Strengthened leadership team with appointments of Luca Scavo as Chief Financial Officer and Julie H. McHugh to Board of Directors- -Announced strategic collaboration with Abdul Latif Jameel Health to develop and commercialize EDP1815 in select developing markets- -Multiple clinical data readouts expected over next 18 months- -Management to host conference call at 8:30 a.m. ET- CAMBRIDGE, Mass., April 29, 2021 (GLOBE NEWSWIRE) Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today reported financial results and business highlights for the first quarter 2021.

Evelo Biosciences Reports First Quarter 2021 Financial Results and Business Highlights

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Evelo Biosciences Reports First Quarter 2021 Financial Results and Business Highlights Evelo Biosciences, Inc.April 29, 2021 GMT –Presented further positive data from Phase 1b clinical trial of EDP1815 at International Society of Atopic Dermatitis Meeting– –Strengthened leadership team with appointments of Luca Scavo as Chief Financial Officer and Julie H. McHugh to Board of Directors– –Announced strategic collaboration with Abdul Latif Jameel Health to develop and commercialize EDP1815 in select developing markets– –Multiple clinical data readouts expected over next 18 months– –Management to host conference call at 8:30 a.m. ET–

Evelo Biosciences, Inc (EVLO) Q1 2021 Earnings Call Transcript

Evelo Biosciences, Inc. (EVLO) Q1 2021 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Evelo Biosciences, Inc. (NASDAQ: EVLO) Q1 2021 Earnings Call Good morning, and welcome to Evelo Biosciences conference call to discuss the first-quarter 2021 financial results and business highlights. [Operator instructions] Please be advised that this call is being recorded at the company s request. At this time, I d like to turn the call over to Jessica Cotrone of Evelo. Please proceed. Jessica Cotrone Vice President, Head of of Communications Thank you. This morning we issued the press release that outlines the topics we plan to discuss today. This release is available at www.evelobio.com under the investors tab. Today in our call, we have Simba Gill, chief executive officer; Mark Bodmer, president of R&D and chief scientific officer; and Jonathan Zung, chief development officer.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.